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Abstract
An improved method for the asymetric alkylation of 3-bromooxindoles with α-arylated malonate 
esters is described. The asymmetric alkylation demonstrated was achieved up to 70% ee utilizing a 
copper(II) bis(phosphine) complex.
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1. Introduction
3,3-Disubstituted oxindole moieties are present in a wide variety of natural products and 
pharmaceutical agents.1 Accordingly, methods for the asymmetric construction of 3,3-
disubstituted oxindoles have attracted considerable attention from the synthetic community, 
and a number of catalytic stereoselective approaches to provide C3 quaternary stereocenters 
on oxindoles have been reported.2,3 In 2007, we discovered that 3,3-disubstituted oxidoles 3 
were furnished efficiently by base-mediated alkylation of reactive electrophilic o-
azaxylyxene 2, generated from 3-halooxindole 1, with nucleophilic malonate esters (Scheme 
1a).4a Additionally, we developed a method for the stereoselective alkylation of 3-
bromooxindoles by using a copper (R)-Ph-BOX ligand complex (Scheme 1b).4b
Following our development of these methods, our attention turned to the syntheses of the 
polycyclic alkaloids communesin F and perophoramidine.5,6 We envisioned that the 
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stereochemistry at the vicinal quaternary centers on communesin F and perophoramidine 
could be installed utilizing the conditions described in Scheme 1b. However, attempts to 
produce diesters 8 and 9 via copper(II) bisoxazoline catalyzed enantioselective alkylation of 
3-bromooxindoles 4 and 5 with α-arylated malonate esters 6 and 7 were unsuccessful 
(Scheme 2). Perhaps this result was to be expected, since the nucleophiles (α-arylated 
malonate esters 6 and 7) were both sterically demanding and electronically deactivated by 
resonance stabilization through the o-nitrophenyl substituent. Therefore, we pursued the 
development of an alternative catalytic system.
In our previous studies, we tested a variety of metal catalysts (e.g. CuII, MgII, LaIII, and NiII) 
and discovered that the combination of CuII and a chiral bisoxazoline ligand effectively 
promoted the catalytic reaction.4 Chiral Cu(II) bis(phosphine) complexes have also found 
use in stereoselective synthesis.7 Since the catalytic system can be formed with a number of 
different chiral bis(phosphine) ligands, quite a few options would be available for 
developing a stereoselective reaction. Herein, we describe several screening studies 
designed and undertaken to optimize the reaction conditions for the alkylation of 3-
bromooxindoles with α-arylated malonate esters using a copper(II) bis(phosphine) catalyst.
2. Results and discussion
2.1. Initial screening results
To develop a stereoselective alkylation method, we chose simple substrates for optimization 
studies; specifically, we used bromooxindole 5 without a substituent on the aromatic ring 
and o-nitrophenyl dimethylmalonate 12 as a coupling partner. Bromooxindole 5 was easily 
prepared from indole in four steps by a known sequence,5 which was then added to o-
nitrophenyl dimethylmalonate 12 and cesium carbonate in THF solvent to afford a racemic 
product 13 in good yield. (Scheme 3).
Choosing (R)-BINAP as a chiral ligand, we began our research by screening various copper 
sources, bases, and solvents. For instance we attempted the following variations of copper 
ions: Copper(II) triflate, copper(II) chloride with silver hexafluoroantimonate, copper(II) 
isobutyrate, copper(II) tert-butoxide (generated in situ by adding lithium tert-butoxide to 
copper(II) isobutyrate and ligand mixture), copper(II) ethylhexanoate, and copper(II) 
trifluoroacetylacetonate. We explored both organic and inorganic bases, including 
diisopropylethylamine, pyridine, tetramethylethylenediamine (TMEDA), triethylamine, 
diisopropylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), sodium carbonate, potassium 
acetate, sodium ethylhexanoate and cesium carbonate. The various reactions combinations 
were attempted in the following solvents: dichloromethane, tetrahydrofuran, benzene, 
acetonitrile, and dioxane. Evaluating the 93 reactions that were explored,8 we found that 
copper(II) tert-butoxide and the ligand complex generated in THF, which was similar to 
Fandrick’s conditions for asymmetric propargylation,7 exhibited the best reactivity without 
generation of side products for the coupling of the arylated malonate 12 and bromooxindole 
5 in CH2Cl2 (high conversion, 20% ee).
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2.2. Ligand screening and optimization studies
Based on previous studies, we selected copper(II) isobutyrate, lithium tert-butoxide and 
THF solvent for generation of the catalytic species with chiral ligands, diisopropylamine as 
the base and CH2Cl2 as solvent. We have screened 69 chiral bis(phosphine) ligands8 under 
similar condition, finding WALPHOS and DiazaPHOS to give the best enantioselectivities 
(Figure 1).
Having identified the most effective ligands, we next screened several copper sources under 
lower temperatures. Although none of these sources exhibited better results than the 
combination of copper(II) isobutyrate and lithium tert-butoxide for WALPHOS (N1 and 
N2), we were able to observe better stereoselectivity at low temperature (Table 1, entries 6 
and 16). With DiazaPHOS (W1), copper(II) triflate showed better selectivity at 0 °C (Table 
1, entries 22 and 23).
With a suitable bis(phosphine) ligand in hand (N1), we tested multiple solvents and bases. 
However, amine bases weaker than Hünig’s base (Table 2, entries 1-12) could not initiate 
the reaction, whereas stronger base (entries 13-18) decreased the stereoselectivity. The 
copper bis(phosphine) complex demonstrated similar selectivity in dichloromethane (entry 
19), THF (entry 20), and chloroform (entry 22), however it showed worse selectivity in 
acetonitrile (entry 21) and failed to proceed at all in toluene and 1,2-dimethoxyethane 
(DME).
In addition to these studies, we examined the effect of the catalyst and ligand loading on the 
stereoselectivity of our alkylation reaction. Unsatisfactory results were produced with low 
catalyst or ligand loading (Table 3, entries 1,2 and 4), but 20 mol % of copper(II) isobutyrate 
and 40 mol % of the ligand gave the product in 56% ee (Table 3, entry 3). Stoichiometric 
amounts of the copper presursor and ligand produced only a slight increase in ee (Table 3, 
entry 5). Additionally, we investigated the impact of the equivalents of Hünig’s base on the 
selectivity of the reaction. Results showed the amount of Hünig’s base had little effect on 
the stereoselectivity of the product (Table 3, entries 6-13). Subsequent examination of 
concentration effects showed lowering the concentration of the reaction mixture from 0.05 
M to 0.02 M resulted in increase stereoselectivity (Table 4).
Finally, we explored a set of WALPHOS ligands (N1 – N8) under our optimized conditions. 
Gratifyingly, we observed improved ee by using (Ph,Cy)-WALPHOS (Table 5, entry 5), 
leading to product formation in 70% ee with moderate conversion, whereas other ligands 
showed diminished selectivity. To date, this is the best result we have, which is a great 
improvement over the starting point.
3. Conclusion
Asymmetric alkylation of 3-halooxindoles with malonate esters is an effective method to 
construct 3,3,-disubstituted oxindole moieties. Herein, we have reported that copper(II) 
chiral bis(phosphine) complex demonstrated reactivity with a highly stabilized and sterically 
hindered α-arylated malonate ester, which were unreactive substrates in previously 
developed conditions. This method could be applied to the installation of vicinal quaternary 
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centers on the communesin F and perophoramidine scaffolds and could be useful in the 
synthesis of a variety of other natural products.
4. Selected experimentals
4.1. Synthesis of rac-13
To a flame-dried round-bottomed flask equipped with a stirbar, was added bromooxindole 5 
(20 mg, 0.045 mmol), o-nitrophenyl dimethylmalonate 12 (37 mg, 0.135 mmol) and THF 
(0.5 mL). To the mixture was added cesium carbonate (47.4 mg, 0.045 mmol) at ambient 
temperature and the reaction mixture was then stirred for 3 hr. The reaction mixture was 
then treated with saturated NH4Cl aqueous solution, extracted with EtOAc, washed with 
brine and dried over MgSO4. After concentration in vacuo, the crude product was obtained. 
Chromatography (6:1 hexanes: ethyl acetate) on silica gel afforded the title compound 13 
(23 mg, 80% yield) as colorless oil: 1H NMR (500 MHz, CDCl3) δ 8.0 (d, J = 8.1 Hz, 1H), 
7.85 (s, 1H), 7.74 (dd, J = 7.9, 1.7 Hz, 1H), 7.40 (dtd, J = 26.6, 7.4, 1.5 Hz, 2H), 7.30 (d, J = 
7.8 Hz, 1H), 7.14 (td, J = 7.7, 1.3 Hz, 1H), 6.90 (td, J = 7.7, 1.2 Hz,1H), 6.75 (dd, J = 7.8, 
1.1 Hz, 1H), 3.74 (s, 3H), 3.65 (s, 3H), 3.35 (ddd, J = 9.5, 8.4, 6.9 Hz, 1H), 3.06 (td, J = 9.3, 
4.5, 1H), 2.93 (ddd, J = 12.6, 8.8, 6.7 Hz, 1H), 2.54 (ddd, J = 12.8, 8.4, 4.4 Hz, 1H), 0.89 (s, 
21H). 13C NMR (126 MHz, CDCl3) δ 177.86, 167.63, 167.27, 150.34, 140.67, 132.46, 
131.12, 129.49, 129.23, 128.63, 128.61, 126.73, 125.39, 122.45, 109.98, 109.12, 59.52, 
56.71, 52.81, 52.80, 38.34, 29.70, 17.85, 17,84, 11.80. IR (Neat Film, NaCl) 2923, 2852, 
1722, 1617, 1532, 1463, 1353, 1259, 1097, 992, 799, 753 cm−1; HRMS (MM) m/z calc’d for 
C30H40N2O8Si [M+H]+: 585.2627, found 585.2636.
4.2. Ligand Screening procedure
Every step was performed in a nitrogen-filled glove box. Solutions of copper(II) isoburtyrate 
(8 mg, 0.034 mmol) in THF (3.5 mL), lithium tert-butoxide (2.72 mg, 0.034 mmol) in THF 
(3.5 mL), bromooxindole 5 (70 mg, 0.17 mmol) and malonate 12 (129 mg, 0.51 mmol) in 
CH2Cl2 (1.75 mL), i-Pr2NEt (0.1 ml, 0.57 mmol) in CH2Cl2 (2 mL) were prepared in 2 
dram vials prior to reaction setup. To 1 dram vials equipped with stirbars, and ligand (1.1 
μmol, 22 mol %) were distributed copper(II) isobutyrate in THF (0.1 mL, 0.97 μmol, 20 mol 
%). The heterogeneous solution was agitated at room temperature for 10-20 min until a clear 
homogeneous solution was generated. The reaction mixtures were charged with lithium tert-
butoxide in THF (0.1 mL, 0.97 μmol, 20 mol %). Reaction mixtures were allowed to stir for 
5 min and concentrated under reduced pressure. A mixture of bromooxindole 5 and 
malonate 12 in CH2Cl2 (0.05 mL, 4.85 μmol, 14.55 μmol) was dispensed to each vial and 
allowed to stir for 10 min. After setting the reaction temperature, i-Pr2NEt in CH2Cl2 (0.05 
mL, 14.55 μmol, 3 equiv) was added to the reaction vials and allowed to stir for 48 h. Upon 
completion, sat. aq. ammonium chloride solution (0.1 mL) was added, and the mixture was 
filtered through silica gel. Each filtrate was diluted by 1 mL of solvent (ethyl acetate or 
isopropanol) and analyzed by chiral SFC. The mixture was separated by an AD-H column 
with 20% isopropanol as eluent. See supplementary material for more details.
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Figure 1. 
Results with DiazaPHOS and WALPHOS
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Scheme 1. 
Construction of 3,3-disubstituted oxindoles by alkylation of 3-halooxindoles.
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Scheme 2. 
Attempts for alkylation of 3-bromooxindoles with α-arylated malonate esters.
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Scheme 3. 
Synthesis of the racemic product.
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Table 1
Further investigations using WALPHOS and DiazaPHOS in the alkylation reaction.
Entry Metal Sources Ligand Additive Temp. eea
1 CuCl2 N1 AgBF4 −45 °C –
2 CuCl2 N1 AgNTf2 −45 °C –
3 CuCl2 N1 AgPF6 −45 °C –
4 CuCl2 N1 AgSbF6 −45 °C –
5 CuCl2 N1 LiOt-Bu −45 °C –
6 Cu(isobutyrate)2 N1 LiOt-Bu −45 °C 44%
7 Cu(isobutyrate)2 N1 AgSbF6 −45 °C –
8 Cu(hfacac)2 N1 −45 °C trace
9 Cu(OTf)2 N1 −45 °C trace
10 Cu(OTf)2 N1 LiOt-Bu −45 °C 23%
11 Cu(EH)2 N1 −45 °C trace
12 CuCl2 N2 AgBF4 −45 °C –
13 CuCl2 N2 AgNTf2 −45 °C –
14 CuCl2 N2 AgPF6 −45 °C –
15 CuCl2 N2 AgSbF6 −45 °C –
16 Cu(isobutyrate)2 N2 LiOt-Bu −45 °C 54%
17 Cu(hfacac)2 N2 −45 °C 30%
18 Cu(OTf)2 N2 −45 °C 45%
19 Cu(EH)2 N2 −45 °C trace
20 Cu(isobutyrate)2 W1 LiOt-Bu 0 °C trace
21 Cu(isobutyrate)2 W1 b LiOt-Bu 0 °C trace
22 Cu(OTf)2 W1 0 °C 40%
23 Cu(OTf)2 W1 b 0 °C 50%
Conditions: 0.0049 mmol 5, 0.0145 mmol 12, Cu (20 mol %), Ligand (22 mol %), Additive (20 mol %), i-Pr2NEt (3 equiv.), 0.1 mL CH2Cl2 
(0.049 M). Metal catalyst, ligand and additives were mixed in THF. THF was removed in vacuo, and the resultant was diluted with the reaction 
solvent. The reaction was initiated by addition of base. Cu(hfacac)2: copper(II) hexafluoroacetylacetonate, Cu(EH)2: copper(II) ethylhexanoate.
–: Desired product was not observed.
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a
enantiomeric excess was measured by chiral SFC.
b44 mol % of ligand was used.
Tetrahedron. Author manuscript; available in PMC 2016 June 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Lee et al. Page 13
Table 2
Investigation of reaction solvents and bases with WALPHOS in the alkylation reaction.
Entry Solvent Base ee
1 CH2Cl2 DABCO –
2 THF DABCO –
3 CH3CN DABCO –
4 CHCl3 DABCO –
5 Toluene DABCO –
6 DME DABCO –
7 CH2Cl2 DMAP –
8 THF DMAP –
9 CH3CN DMAP –
10 CHCl3 DMAP –
11 Toluene DMAP –
12 DME DMAP –
13 CH2Cl2 Cs2CO3 35%
14 THF Cs2CO3 15%
15 CH3CN Cs2CO3 20%
16 CHCl3 Cs2CO3 20%
17 Toluene Cs2CO3 –
18 DME Cs2CO3 10%
19 CH2Cl2 i-Pr2NEt 40%
20 THF i-Pr2NEt 50%
21 CH3CN i-Pr2NEt 30%
22 CHCl3 i-Pr2NEt 40%
23 Toluene i-Pr2NEt –
24 DME i-Pr2NEt –
Conditions: 0.0024 mmol 5, 0.0072 mmol 12, Cu (20 mol %), Ligand (22 mol %), LiOt-Bu (20 mol %), Base (3 equiv), 0.06 mL Solvent (0.04 M).
–: Desired product was not observed.
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Table 3
Examination of the amount of catalyst and ligand loading in the alkylation reaction.
Entry Cu(isobutyrate)2 Ligand i-Pr2NEt ee
1 10 mol % 10 mol % 3.0 equiv 25%
2 10 mol % 20 mol % 3.0 equiv 28%
3 20 mol % 40 mol % 3.0 equiv 56%
4 20 mol % 10 mol % 3.0 equiv 35%
5 1 equiv 1 equiv 3.0 equiv 60%
6 20 mol % 20 mol % 1.0 equiv 33%
7 20 mol % 20 mol % 1.5 equiv 35%
8 20 mol % 20 mol % 2.0 equiv 38%
9 20 mol % 20 mol % 2.5 equiv 37%
10 20 mol % 20 mol % 4.0 equiv 36%
11 20 mol % 20 mol % 5.0 equiv 37%
12 20 mol % 20 mol % 6.0 equiv 36%
13 20 mol % 20 mol % 20 equiv 36%
Conditions: 0.0049 mmol 5, 0.0145 mmol 12, LiOt-Bu (10 mol %), 0.1 mL CH2Cl2 (0.049 M).
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Table 4
Examination of concentration in the malonate addition reaction.
Entry Concentration ee
1 0.005 M 53%
2 0.01 M 63%
3 0.02 M 64%
4 0.05 M 55%
5 0.25 M 40%
Conditions: 0.0049 mmol 5, 0.0145 mmol 13, Cu (20 mol %), Ligand (40 mol %), LiOt-Bu (20 mol %), i-Pr2NEt (3 equiv).
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Table 5
The effect of WALPHOS substituents under optimized condition in the alkylation reaction.
Entry Ligand ee
1 N1 60%
2 N2 trace
3 N3 25%
4 N4 25%
5 N5 70%
6 N6 –
7 N7 –
8 N8 –
Conditions: 0.0049 mmol 5, 0.0145 mmol 12, Cu (20 mol %), Ligand (40 mol %), LiOt-Bu (20 mol %), i-Pr2NEt (3 equiv), 0.25 mL CH2Cl2 
(0.02 M).
–: Desired product was not observed.
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